Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.

The Journal of pathology - 1 Mar 2007

Hu B, Ullenbruch M R, Jin H, Gharaee-Kermani M, Phan S H

Abstract excerpt

Pulmonary fibrosis is characterized by inflammation, genesis of myofibroblasts, and abnormal tissue repair. Despite extensive research, its pathogenesis remains incompletely understood. Previously, the transcription factor CCAAT/enhancer binding protein beta (C/EBPbeta) was found to be a key regulator of myofibroblast differentiation in vitro, and to be involved in the acute phase and inflammatory responses. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actins
Share to Antibiotics, Antineoplastic
Share to Bleomycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CCAAT-Enhancer-Binding Protein-beta

Share to Collagen

Share to Muscle, Smooth

Share to Pulmonary Fibrosis

Source

Identifiers

PMID: 17177178
DOI: 10.1002/path.2119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.PMID 17177178Read ↗

CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional UnderstandingSemantic proximity Read ↗

Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.Semantic proximity Read ↗

CREPT is required for pulmonary fibrosis induced by bleomycinSemantic proximity Read ↗

Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosisSemantic proximity Read ↗

Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPDSemantic proximity Read ↗

Therapies for bleomycin induced lung fibrosis through regulation of TGF‐β1 induced collagen gene expressionSemantic proximity Read ↗

Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.Semantic proximity Read ↗

C/EBPβ Acetylation is Involved in Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiationSemantic proximity Read ↗

Highly Calibrated Relationship Between Bleomycin Concentrations and Facets of the Active Phase Fibrosis in Classical Mouse Bleomycin ModelSemantic proximity Read ↗

BET Bromodomain Proteins Mediate Downstream Signaling Events following Growth Factor Stimulation in Human Lung Fibroblasts and Are Involved in Bleomycin-Induced Pulmonary FibrosisSemantic proximity Read ↗

Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.